相关实验视频
Updated: May 21, 2025

05:18
A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
Published on: February 17, 2023
3.5K
益血管性循环纳米管用于糖尿病伤口愈合
Vatan Chawla1, Soumyajit Roy2, John Raju1
1Department of Chemistry, Indian Institute of Technology Ropar, Rupnagar-140 001, Punjab India.
ACS applied bio materials
|March 19, 2025
概括
研究人员开发了heparan硫酸盐模拟循环纳米管,以促进糖尿病伤口中的血管形成. 这些新型纳米管增强了无生长因子的血管生成,为慢性伤口愈合提供了有前途的新疗法.
科学领域:
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
- 生物化学 生物化学
背景情况:
- 慢性伤口,如糖尿病足,表现出较差的血管生成,阻碍愈合.
- 目前促进血管生成的疗法面临着不稳定性和免疫性等挑战.
- 肝硫酸盐 (HS) 对于生长因子信号传递至关重要,但难以外源地施用.
研究的目的:
- 为增强血管生成开发新型肝素硫酸盐 (HS) 模仿循环纳米管 (CPNTs).
- 在高血糖条件下研究这些CPNT的益血管性潜力.
- 评估CPNTs作为糖尿病伤口愈合治疗策略的有效性,而无需外部生长因子.
主要方法:
- 合成的硫化循环六胺纳米管模仿甲酸硫酸的功能组.
- 在质结构中加入了谷氨酸,血清素和硫酸素.
- 在高血糖条件下使用人静脉内皮细胞 (HUVEC) 评估了CPNT的益血管性活性.
主要成果:
- 开发的CPNTs在HUVECs中表现出显著的益血管性活性.
- CPNTs增强了内皮细胞的运动性,入侵性和管道形成.
- 观察到关键的益血管性基因和蛋白质的升级,表明有效的信号传递.
结论:
- 肝素硫酸盐模拟循环纳米管显示出促进受损血管生成的强大潜力.
- 这些新型纳米管为治疗糖尿病伤口提供了一个有希望的,无生长因子的方法.
- 这项研究代表了关于HS模拟性亲血管性循环纳米管用于糖尿病伤口愈合的第一份报告.
相关概念视频
Mechanism of Angiogenesis
5.2K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.2K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K

